Steven J. Chmura, MD, PhD, compares addition of metastases-directed therapy vs SOC alone for oligometastatic breast cancer
Steven J. Chmura, MD, PhD, discussed recent findings from the phase 2R/3 NRG-BR002 trial in patients with newly diagnosed oligometastatic breast cancer.
Cancer fatalism common among rural residents
Cancer misinformation may be more prevalent among residents in rural vs urban areas, study finds.
FDA grants olaparib priority review in BRCA-mutated HER2-negative high-risk early breast cancer
Olaparib, which was granted priority review by the FDA, has been shown to improve invasive disease-free survival for patients with BRCA-mutated HER2-negative high-risk early breast cancer.
Consideration towards the psychosocial support needs of patients with breast cancer who have dependent children is imperative
Attention needs to be paid to the psychosocial needs of patients, especially those with poor health-related quality of life, who have little support, or are single mothers.
2 Clarke Drive Cranbury, NJ 08512